Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Discovery Medicine|August 14, 2010
Targeting therapeutic molecules to sites of diseaseYuti Chernajovsky, Sandrine Vessillier, Gill AdamsProtein Engineering, Design & Selection : PEDS|February 15, 2005
Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3Sandrine Vessillier, Gill Adams, Yuti ChernajovskyJournal of Visualized Experiments : Jove|October 2, 2023
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody SafetyElliot MacLeod, Deepa Rajagopal, Sandrine VessillierViruses|August 28, 2021
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future PerspectivesRoman P Labbé, Sandrine Vessillier, Qasim A RafiqNature Biotechnology|October 7, 2003
Targeting cytokines to inflammation sitesGill Adams, Sandrine Vessillier, Hanna Dreja, et al.Journal of Cellular and Molecular Medicine|July 4, 2024
Immune-related adverse events of antibody-based biological medicines in cancer therapyDeepa Rajagopal, Elliot MacLeod, Diana Corogeanu, et al.Frontiers in Immunology|April 6, 2026
Evaluation of a reference antibody panel for prediction of cytokine release in humanised mouse models in vivoDeepa Rajagopal, Ka Seng Ieong, Ryan Mate, et al.Trends in Molecular Medicine|June 5, 2004
Methods for targeting biologicals to specific disease sitesAhuva Nissim, Yarunnessa Gofur, Sandrine Vessillier, et al.Journal of Immunology and Regenerative Medicine|June 7, 2021
An accurate and rapid single step protocol for enumeration of cytokine positive T lymphocytesDeepa Rajagopal, Linhua Tian, Shiqiu Xiong, et al.Arthritis Research & Therapy|November 30, 2013
Low oxygen tension increased fibronectin fragment induced catabolic activities--response prevented with biomechanical signalsEleanor Parker, Sandrine Vessillier, Belinda Pingguan-Murphy, et al.Pageof 3